nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefepime—SLC15A2—melanoma	0.72	1	CbGaD
Cefepime—SLC22A5—Dactinomycin—melanoma	0.169	1	CbGbCtD
Cefepime—Status epilepticus—Temozolomide—melanoma	0.00353	0.034	CcSEcCtD
Cefepime—Altered state of consciousness—Temozolomide—melanoma	0.0018	0.0174	CcSEcCtD
Cefepime—Local reaction—Bleomycin—melanoma	0.00178	0.0172	CcSEcCtD
Cefepime—Nephropathy toxic—Bleomycin—melanoma	0.00171	0.0165	CcSEcCtD
Cefepime—Nephropathy toxic—Carmustine—melanoma	0.0015	0.0144	CcSEcCtD
Cefepime—Neurotoxicity—Docetaxel—melanoma	0.00142	0.0137	CcSEcCtD
Cefepime—Oral candidiasis—Carmustine—melanoma	0.00135	0.0131	CcSEcCtD
Cefepime—Encephalopathy—Carmustine—melanoma	0.00134	0.0129	CcSEcCtD
Cefepime—Oral candidiasis—Temozolomide—melanoma	0.00131	0.0126	CcSEcCtD
Cefepime—Ceftibuten—SLC15A2—melanoma	0.00118	0.217	CrCbGaD
Cefepime—Stupor—Carmustine—melanoma	0.00115	0.0111	CcSEcCtD
Cefepime—Extravasation—Bleomycin—melanoma	0.00113	0.0109	CcSEcCtD
Cefepime—Cholestasis—Temozolomide—melanoma	0.00109	0.0106	CcSEcCtD
Cefepime—Toxic epidermal necrolysis—Vemurafenib—melanoma	0.00106	0.0103	CcSEcCtD
Cefepime—Extravasation—Dactinomycin—melanoma	0.00105	0.0102	CcSEcCtD
Cefepime—Eosinophilia—Vemurafenib—melanoma	0.00101	0.00974	CcSEcCtD
Cefepime—Hypocalcaemia—Dactinomycin—melanoma	0.001	0.00968	CcSEcCtD
Cefepime—Extravasation—Carmustine—melanoma	0.000985	0.00951	CcSEcCtD
Cefepime—Stevens-Johnson syndrome—Vemurafenib—melanoma	0.000902	0.0087	CcSEcCtD
Cefepime—Cefuroxime—SLC15A2—melanoma	0.000882	0.162	CrCbGaD
Cefepime—Oral candidiasis—Docetaxel—melanoma	0.00087	0.00839	CcSEcCtD
Cefepime—Aplastic anaemia—Dactinomycin—melanoma	0.000862	0.00832	CcSEcCtD
Cefepime—Vaginal inflammation—Temozolomide—melanoma	0.000831	0.00802	CcSEcCtD
Cefepime—Phosphatase alkaline increased—Temozolomide—melanoma	0.000831	0.00802	CcSEcCtD
Cefepime—Depressed level of consciousness—Carmustine—melanoma	0.00083	0.00801	CcSEcCtD
Cefepime—Phlebitis—Bleomycin—melanoma	0.00083	0.00801	CcSEcCtD
Cefepime—Candida infection—Carmustine—melanoma	0.000821	0.00792	CcSEcCtD
Cefepime—SLC15A1—Proton/oligonucleotide cotransporters—SLC15A2—melanoma	0.000813	0.387	CbGpPWpGaD
Cefepime—Liver disorder—Docetaxel—melanoma	0.000811	0.00782	CcSEcCtD
Cefepime—Depressed level of consciousness—Temozolomide—melanoma	0.000802	0.00774	CcSEcCtD
Cefepime—Sepsis—Dactinomycin—melanoma	0.000797	0.00769	CcSEcCtD
Cefepime—Candida infection—Temozolomide—melanoma	0.000793	0.00765	CcSEcCtD
Cefepime—Coma—Carmustine—melanoma	0.000786	0.00758	CcSEcCtD
Cefepime—Vaginal infection—Temozolomide—melanoma	0.000784	0.00757	CcSEcCtD
Cefepime—Aplastic anaemia—Temozolomide—melanoma	0.00078	0.00753	CcSEcCtD
Cefepime—Phlebitis—Dactinomycin—melanoma	0.000774	0.00747	CcSEcCtD
Cefepime—Erythema multiforme—Vemurafenib—melanoma	0.000772	0.00745	CcSEcCtD
Cefepime—Cefixime—SLC15A2—melanoma	0.000762	0.14	CrCbGaD
Cefepime—Sepsis—Carmustine—melanoma	0.000746	0.0072	CcSEcCtD
Cefepime—Hepatic failure—Dactinomycin—melanoma	0.000742	0.00716	CcSEcCtD
Cefepime—Chills—Vemurafenib—melanoma	0.000732	0.00707	CcSEcCtD
Cefepime—Phlebitis—Carmustine—melanoma	0.000724	0.00699	CcSEcCtD
Cefepime—Ceftazidime—SLC15A2—melanoma	0.000717	0.131	CrCbGaD
Cefepime—Erythema—Vemurafenib—melanoma	0.000711	0.00686	CcSEcCtD
Cefepime—Cefdinir—SLC15A2—melanoma	0.000704	0.129	CrCbGaD
Cefepime—Dysgeusia—Vemurafenib—melanoma	0.000696	0.00671	CcSEcCtD
Cefepime—Blood alkaline phosphatase increased—Temozolomide—melanoma	0.000693	0.00669	CcSEcCtD
Cefepime—Hepatic failure—Temozolomide—melanoma	0.000671	0.00647	CcSEcCtD
Cefepime—Extravasation—Docetaxel—melanoma	0.000633	0.00611	CcSEcCtD
Cefepime—Toxic epidermal necrolysis—Dactinomycin—melanoma	0.0006	0.00579	CcSEcCtD
Cefepime—Pancytopenia—Bleomycin—melanoma	0.000587	0.00566	CcSEcCtD
Cefepime—Anaphylactic shock—Vemurafenib—melanoma	0.00058	0.0056	CcSEcCtD
Cefepime—Infection—Vemurafenib—melanoma	0.000576	0.00556	CcSEcCtD
Cefepime—Inflammation—Docetaxel—melanoma	0.00057	0.0055	CcSEcCtD
Cefepime—Pneumonia—Bleomycin—melanoma	0.000554	0.00535	CcSEcCtD
Cefepime—Phosphatase alkaline increased—Docetaxel—melanoma	0.000553	0.00533	CcSEcCtD
Cefepime—Cefotaxime—SLC15A2—melanoma	0.000551	0.101	CrCbGaD
Cefepime—Pancytopenia—Dactinomycin—melanoma	0.000547	0.00528	CcSEcCtD
Cefepime—Ceftriaxone—SLC15A2—melanoma	0.000543	0.0995	CrCbGaD
Cefepime—Toxic epidermal necrolysis—Temozolomide—melanoma	0.000543	0.00524	CcSEcCtD
Cefepime—Neutropenia—Dactinomycin—melanoma	0.000539	0.0052	CcSEcCtD
Cefepime—Alanine aminotransferase increased—Temozolomide—melanoma	0.000532	0.00513	CcSEcCtD
Cefepime—Colitis—Docetaxel—melanoma	0.00053	0.00512	CcSEcCtD
Cefepime—Candida infection—Docetaxel—melanoma	0.000527	0.00509	CcSEcCtD
Cefepime—Pneumonia—Dactinomycin—melanoma	0.000517	0.00499	CcSEcCtD
Cefepime—Pancytopenia—Carmustine—melanoma	0.000512	0.00494	CcSEcCtD
Cefepime—Stevens-Johnson syndrome—Dactinomycin—melanoma	0.000509	0.00491	CcSEcCtD
Cefepime—Neutropenia—Carmustine—melanoma	0.000504	0.00487	CcSEcCtD
Cefepime—Bronchitis—Temozolomide—melanoma	0.000501	0.00484	CcSEcCtD
Cefepime—Gastrointestinal disorder—Vemurafenib—melanoma	0.000501	0.00483	CcSEcCtD
Cefepime—Haemoglobin—Bleomycin—melanoma	0.000497	0.0048	CcSEcCtD
Cefepime—Constipation—Vemurafenib—melanoma	0.000496	0.00478	CcSEcCtD
Cefepime—Pancytopenia—Temozolomide—melanoma	0.000495	0.00478	CcSEcCtD
Cefepime—Haemorrhage—Bleomycin—melanoma	0.000495	0.00477	CcSEcCtD
Cefepime—Neutropenia—Temozolomide—melanoma	0.000487	0.0047	CcSEcCtD
Cefepime—Pneumonia—Carmustine—melanoma	0.000484	0.00467	CcSEcCtD
Cefepime—Agranulocytosis—Dactinomycin—melanoma	0.00048	0.00463	CcSEcCtD
Cefepime—Sepsis—Docetaxel—melanoma	0.000479	0.00463	CcSEcCtD
Cefepime—Renal failure—Carmustine—melanoma	0.000473	0.00456	CcSEcCtD
Cefepime—Urinary tract infection—Carmustine—melanoma	0.000467	0.00451	CcSEcCtD
Cefepime—Pneumonia—Temozolomide—melanoma	0.000467	0.00451	CcSEcCtD
Cefepime—Phlebitis—Docetaxel—melanoma	0.000466	0.00449	CcSEcCtD
Cefepime—Blood alkaline phosphatase increased—Docetaxel—melanoma	0.000461	0.00445	CcSEcCtD
Cefepime—Stevens-Johnson syndrome—Temozolomide—melanoma	0.000461	0.00445	CcSEcCtD
Cefepime—Body temperature increased—Vemurafenib—melanoma	0.000458	0.00442	CcSEcCtD
Cefepime—Urinary tract infection—Temozolomide—melanoma	0.000452	0.00436	CcSEcCtD
Cefepime—Hepatic failure—Docetaxel—melanoma	0.000446	0.00431	CcSEcCtD
Cefepime—Chills—Bleomycin—melanoma	0.000444	0.00428	CcSEcCtD
Cefepime—Erythema multiforme—Dactinomycin—melanoma	0.000436	0.00421	CcSEcCtD
Cefepime—Haemoglobin—Carmustine—melanoma	0.000434	0.00419	CcSEcCtD
Cefepime—Haemorrhage—Carmustine—melanoma	0.000432	0.00417	CcSEcCtD
Cefepime—Erythema—Bleomycin—melanoma	0.000431	0.00415	CcSEcCtD
Cefepime—Hallucination—Carmustine—melanoma	0.00043	0.00414	CcSEcCtD
Cefepime—Hypersensitivity—Vemurafenib—melanoma	0.000427	0.00412	CcSEcCtD
Cefepime—Renal impairment—Docetaxel—melanoma	0.000421	0.00407	CcSEcCtD
Cefepime—Haemoglobin—Temozolomide—melanoma	0.000419	0.00405	CcSEcCtD
Cefepime—Haemorrhage—Temozolomide—melanoma	0.000417	0.00403	CcSEcCtD
Cefepime—Hallucination—Temozolomide—melanoma	0.000415	0.004	CcSEcCtD
Cefepime—Chills—Dactinomycin—melanoma	0.000414	0.00399	CcSEcCtD
Cefepime—Pruritus—Vemurafenib—melanoma	0.00041	0.00396	CcSEcCtD
Cefepime—Erythema—Dactinomycin—melanoma	0.000402	0.00387	CcSEcCtD
Cefepime—Anaemia—Bleomycin—melanoma	0.000398	0.00384	CcSEcCtD
Cefepime—Diarrhoea—Vemurafenib—melanoma	0.000397	0.00383	CcSEcCtD
Cefepime—Erythema multiforme—Temozolomide—melanoma	0.000394	0.00381	CcSEcCtD
Cefepime—Leukopenia—Bleomycin—melanoma	0.000385	0.00372	CcSEcCtD
Cefepime—Dizziness—Vemurafenib—melanoma	0.000384	0.0037	CcSEcCtD
Cefepime—Erythema—Carmustine—melanoma	0.000376	0.00363	CcSEcCtD
Cefepime—Chills—Temozolomide—melanoma	0.000374	0.00361	CcSEcCtD
Cefepime—Anaemia—Dactinomycin—melanoma	0.000371	0.00358	CcSEcCtD
Cefepime—Vomiting—Vemurafenib—melanoma	0.000369	0.00356	CcSEcCtD
Cefepime—Rash—Vemurafenib—melanoma	0.000366	0.00353	CcSEcCtD
Cefepime—Dermatitis—Vemurafenib—melanoma	0.000365	0.00352	CcSEcCtD
Cefepime—Headache—Vemurafenib—melanoma	0.000363	0.00351	CcSEcCtD
Cefepime—Erythema—Temozolomide—melanoma	0.000363	0.0035	CcSEcCtD
Cefepime—Toxic epidermal necrolysis—Docetaxel—melanoma	0.000361	0.00348	CcSEcCtD
Cefepime—Leukopenia—Dactinomycin—melanoma	0.000359	0.00347	CcSEcCtD
Cefepime—Dysgeusia—Temozolomide—melanoma	0.000356	0.00343	CcSEcCtD
Cefepime—Confusional state—Bleomycin—melanoma	0.000354	0.00342	CcSEcCtD
Cefepime—Alanine aminotransferase increased—Docetaxel—melanoma	0.000354	0.00341	CcSEcCtD
Cefepime—Anaphylactic shock—Bleomycin—melanoma	0.000351	0.00339	CcSEcCtD
Cefepime—Infection—Bleomycin—melanoma	0.000349	0.00337	CcSEcCtD
Cefepime—Anaemia—Carmustine—melanoma	0.000347	0.00335	CcSEcCtD
Cefepime—Agitation—Carmustine—melanoma	0.000345	0.00333	CcSEcCtD
Cefepime—Nausea—Vemurafenib—melanoma	0.000345	0.00332	CcSEcCtD
Cefepime—Thrombocytopenia—Bleomycin—melanoma	0.000344	0.00332	CcSEcCtD
Cefepime—Leukopenia—Carmustine—melanoma	0.000336	0.00325	CcSEcCtD
Cefepime—Anaemia—Temozolomide—melanoma	0.000336	0.00324	CcSEcCtD
Cefepime—Agitation—Temozolomide—melanoma	0.000334	0.00322	CcSEcCtD
Cefepime—Pancytopenia—Docetaxel—melanoma	0.000329	0.00318	CcSEcCtD
Cefepime—Convulsion—Carmustine—melanoma	0.000326	0.00314	CcSEcCtD
Cefepime—Infection—Dactinomycin—melanoma	0.000326	0.00314	CcSEcCtD
Cefepime—Leukopenia—Temozolomide—melanoma	0.000325	0.00314	CcSEcCtD
Cefepime—Neutropenia—Docetaxel—melanoma	0.000324	0.00313	CcSEcCtD
Cefepime—Thrombocytopenia—Dactinomycin—melanoma	0.000321	0.0031	CcSEcCtD
Cefepime—Paraesthesia—Bleomycin—melanoma	0.000316	0.00304	CcSEcCtD
Cefepime—Convulsion—Temozolomide—melanoma	0.000315	0.00304	CcSEcCtD
Cefepime—Dyspnoea—Bleomycin—melanoma	0.000313	0.00302	CcSEcCtD
Cefepime—Pneumonia—Docetaxel—melanoma	0.000311	0.003	CcSEcCtD
Cefepime—Confusional state—Carmustine—melanoma	0.000309	0.00298	CcSEcCtD
Cefepime—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000306	0.00296	CcSEcCtD
Cefepime—Infection—Carmustine—melanoma	0.000305	0.00294	CcSEcCtD
Cefepime—Renal failure—Docetaxel—melanoma	0.000304	0.00293	CcSEcCtD
Cefepime—Pain—Bleomycin—melanoma	0.0003	0.0029	CcSEcCtD
Cefepime—Thrombocytopenia—Carmustine—melanoma	0.0003	0.0029	CcSEcCtD
Cefepime—Confusional state—Temozolomide—melanoma	0.000299	0.00288	CcSEcCtD
Cefepime—Anaphylactic shock—Temozolomide—melanoma	0.000296	0.00286	CcSEcCtD
Cefepime—Infection—Temozolomide—melanoma	0.000294	0.00284	CcSEcCtD
Cefepime—Thrombocytopenia—Temozolomide—melanoma	0.00029	0.0028	CcSEcCtD
Cefepime—Feeling abnormal—Bleomycin—melanoma	0.00029	0.00279	CcSEcCtD
Cefepime—Agranulocytosis—Docetaxel—melanoma	0.000288	0.00278	CcSEcCtD
Cefepime—Pain—Dactinomycin—melanoma	0.00028	0.0027	CcSEcCtD
Cefepime—Urticaria—Bleomycin—melanoma	0.000279	0.00269	CcSEcCtD
Cefepime—Haemoglobin—Docetaxel—melanoma	0.000279	0.00269	CcSEcCtD
Cefepime—Body temperature increased—Bleomycin—melanoma	0.000278	0.00268	CcSEcCtD
Cefepime—Haemorrhage—Docetaxel—melanoma	0.000277	0.00268	CcSEcCtD
Cefepime—Paraesthesia—Carmustine—melanoma	0.000275	0.00266	CcSEcCtD
Cefepime—Dyspnoea—Carmustine—melanoma	0.000273	0.00264	CcSEcCtD
Cefepime—Feeling abnormal—Dactinomycin—melanoma	0.00027	0.00261	CcSEcCtD
Cefepime—Gastrointestinal pain—Dactinomycin—melanoma	0.000268	0.00259	CcSEcCtD
Cefepime—Paraesthesia—Temozolomide—melanoma	0.000266	0.00257	CcSEcCtD
Cefepime—Gastrointestinal disorder—Carmustine—melanoma	0.000265	0.00255	CcSEcCtD
Cefepime—Dyspnoea—Temozolomide—melanoma	0.000264	0.00255	CcSEcCtD
Cefepime—Erythema multiforme—Docetaxel—melanoma	0.000262	0.00253	CcSEcCtD
Cefepime—Pain—Carmustine—melanoma	0.000262	0.00253	CcSEcCtD
Cefepime—Constipation—Carmustine—melanoma	0.000262	0.00253	CcSEcCtD
Cefepime—Abdominal pain—Dactinomycin—melanoma	0.000259	0.0025	CcSEcCtD
Cefepime—Body temperature increased—Dactinomycin—melanoma	0.000259	0.0025	CcSEcCtD
Cefepime—Hypersensitivity—Bleomycin—melanoma	0.000259	0.0025	CcSEcCtD
Cefepime—Gastrointestinal disorder—Temozolomide—melanoma	0.000256	0.00247	CcSEcCtD
Cefepime—Constipation—Temozolomide—melanoma	0.000253	0.00245	CcSEcCtD
Cefepime—Pain—Temozolomide—melanoma	0.000253	0.00245	CcSEcCtD
Cefepime—Feeling abnormal—Carmustine—melanoma	0.000253	0.00244	CcSEcCtD
Cefepime—Gastrointestinal pain—Carmustine—melanoma	0.000251	0.00242	CcSEcCtD
Cefepime—Chills—Docetaxel—melanoma	0.000249	0.0024	CcSEcCtD
Cefepime—Pruritus—Bleomycin—melanoma	0.000249	0.0024	CcSEcCtD
Cefepime—Feeling abnormal—Temozolomide—melanoma	0.000244	0.00236	CcSEcCtD
Cefepime—Body temperature increased—Carmustine—melanoma	0.000242	0.00234	CcSEcCtD
Cefepime—Abdominal pain—Carmustine—melanoma	0.000242	0.00234	CcSEcCtD
Cefepime—Gastrointestinal pain—Temozolomide—melanoma	0.000242	0.00234	CcSEcCtD
Cefepime—Erythema—Docetaxel—melanoma	0.000242	0.00233	CcSEcCtD
Cefepime—Hypersensitivity—Dactinomycin—melanoma	0.000241	0.00233	CcSEcCtD
Cefepime—Dysgeusia—Docetaxel—melanoma	0.000237	0.00228	CcSEcCtD
Cefepime—Urticaria—Temozolomide—melanoma	0.000235	0.00227	CcSEcCtD
Cefepime—Body temperature increased—Temozolomide—melanoma	0.000234	0.00226	CcSEcCtD
Cefepime—Abdominal pain—Temozolomide—melanoma	0.000234	0.00226	CcSEcCtD
Cefepime—Hypersensitivity—Carmustine—melanoma	0.000226	0.00218	CcSEcCtD
Cefepime—Diarrhoea—Dactinomycin—melanoma	0.000224	0.00216	CcSEcCtD
Cefepime—Vomiting—Bleomycin—melanoma	0.000223	0.00216	CcSEcCtD
Cefepime—Anaemia—Docetaxel—melanoma	0.000223	0.00215	CcSEcCtD
Cefepime—Rash—Bleomycin—melanoma	0.000222	0.00214	CcSEcCtD
Cefepime—Dermatitis—Bleomycin—melanoma	0.000221	0.00214	CcSEcCtD
Cefepime—Hypersensitivity—Temozolomide—melanoma	0.000218	0.00211	CcSEcCtD
Cefepime—Leukopenia—Docetaxel—melanoma	0.000216	0.00209	CcSEcCtD
Cefepime—Diarrhoea—Carmustine—melanoma	0.00021	0.00202	CcSEcCtD
Cefepime—Pruritus—Temozolomide—melanoma	0.00021	0.00202	CcSEcCtD
Cefepime—Convulsion—Docetaxel—melanoma	0.000209	0.00202	CcSEcCtD
Cefepime—Nausea—Bleomycin—melanoma	0.000209	0.00201	CcSEcCtD
Cefepime—Vomiting—Dactinomycin—melanoma	0.000208	0.00201	CcSEcCtD
Cefepime—Rash—Dactinomycin—melanoma	0.000207	0.00199	CcSEcCtD
Cefepime—Dizziness—Carmustine—melanoma	0.000203	0.00196	CcSEcCtD
Cefepime—Diarrhoea—Temozolomide—melanoma	0.000203	0.00196	CcSEcCtD
Cefepime—Confusional state—Docetaxel—melanoma	0.000199	0.00192	CcSEcCtD
Cefepime—Anaphylactic shock—Docetaxel—melanoma	0.000197	0.0019	CcSEcCtD
Cefepime—Dizziness—Temozolomide—melanoma	0.000196	0.00189	CcSEcCtD
Cefepime—Infection—Docetaxel—melanoma	0.000196	0.00189	CcSEcCtD
Cefepime—Vomiting—Carmustine—melanoma	0.000195	0.00188	CcSEcCtD
Cefepime—Nausea—Dactinomycin—melanoma	0.000195	0.00188	CcSEcCtD
Cefepime—Shock—Docetaxel—melanoma	0.000194	0.00187	CcSEcCtD
Cefepime—Rash—Carmustine—melanoma	0.000193	0.00187	CcSEcCtD
Cefepime—Dermatitis—Carmustine—melanoma	0.000193	0.00186	CcSEcCtD
Cefepime—Thrombocytopenia—Docetaxel—melanoma	0.000193	0.00186	CcSEcCtD
Cefepime—Headache—Carmustine—melanoma	0.000192	0.00185	CcSEcCtD
Cefepime—Vomiting—Temozolomide—melanoma	0.000188	0.00182	CcSEcCtD
Cefepime—Rash—Temozolomide—melanoma	0.000187	0.0018	CcSEcCtD
Cefepime—Dermatitis—Temozolomide—melanoma	0.000187	0.0018	CcSEcCtD
Cefepime—Headache—Temozolomide—melanoma	0.000186	0.00179	CcSEcCtD
Cefepime—Nausea—Carmustine—melanoma	0.000182	0.00176	CcSEcCtD
Cefepime—Paraesthesia—Docetaxel—melanoma	0.000177	0.00171	CcSEcCtD
Cefepime—Nausea—Temozolomide—melanoma	0.000176	0.0017	CcSEcCtD
Cefepime—Dyspnoea—Docetaxel—melanoma	0.000176	0.0017	CcSEcCtD
Cefepime—Gastrointestinal disorder—Docetaxel—melanoma	0.00017	0.00164	CcSEcCtD
Cefepime—Pain—Docetaxel—melanoma	0.000169	0.00163	CcSEcCtD
Cefepime—Constipation—Docetaxel—melanoma	0.000169	0.00163	CcSEcCtD
Cefepime—Feeling abnormal—Docetaxel—melanoma	0.000162	0.00157	CcSEcCtD
Cefepime—Gastrointestinal pain—Docetaxel—melanoma	0.000161	0.00156	CcSEcCtD
Cefepime—Abdominal pain—Docetaxel—melanoma	0.000156	0.0015	CcSEcCtD
Cefepime—Body temperature increased—Docetaxel—melanoma	0.000156	0.0015	CcSEcCtD
Cefepime—Hypersensitivity—Docetaxel—melanoma	0.000145	0.0014	CcSEcCtD
Cefepime—Pruritus—Docetaxel—melanoma	0.000139	0.00135	CcSEcCtD
Cefepime—Diarrhoea—Docetaxel—melanoma	0.000135	0.0013	CcSEcCtD
Cefepime—Dizziness—Docetaxel—melanoma	0.00013	0.00126	CcSEcCtD
Cefepime—Vomiting—Docetaxel—melanoma	0.000125	0.00121	CcSEcCtD
Cefepime—Rash—Docetaxel—melanoma	0.000124	0.0012	CcSEcCtD
Cefepime—Dermatitis—Docetaxel—melanoma	0.000124	0.0012	CcSEcCtD
Cefepime—Headache—Docetaxel—melanoma	0.000123	0.00119	CcSEcCtD
Cefepime—Nausea—Docetaxel—melanoma	0.000117	0.00113	CcSEcCtD
Cefepime—Ceftriaxone—ALB—melanoma	0.000117	0.0214	CrCbGaD
Cefepime—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC17A5—melanoma	0.000114	0.0541	CbGpPWpGaD
Cefepime—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC15A2—melanoma	0.00011	0.0521	CbGpPWpGaD
Cefepime—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC17A5—melanoma	0.000105	0.0502	CbGpPWpGaD
Cefepime—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC17A5—melanoma	6.69e-05	0.0318	CbGpPWpGaD
Cefepime—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC15A2—melanoma	6.45e-05	0.0307	CbGpPWpGaD
Cefepime—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC17A5—melanoma	6.21e-05	0.0295	CbGpPWpGaD
Cefepime—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A11—melanoma	5.45e-05	0.026	CbGpPWpGaD
Cefepime—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC5A5—melanoma	4.72e-05	0.0225	CbGpPWpGaD
Cefepime—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC5A5—melanoma	4.38e-05	0.0208	CbGpPWpGaD
Cefepime—SLC15A2—Transmembrane transport of small molecules—ABCB5—melanoma	3e-05	0.0143	CbGpPWpGaD
Cefepime—SLC15A2—SLC-mediated transmembrane transport—SLC17A5—melanoma	2.99e-05	0.0142	CbGpPWpGaD
Cefepime—SLC15A1—SLC-mediated transmembrane transport—SLC15A2—melanoma	2.88e-05	0.0137	CbGpPWpGaD
Cefepime—SLC22A5—SLC-mediated transmembrane transport—SLC15A2—melanoma	2.83e-05	0.0135	CbGpPWpGaD
Cefepime—SLC15A1—Transmembrane transport of small molecules—ABCB5—melanoma	2.79e-05	0.0133	CbGpPWpGaD
Cefepime—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—melanoma	2.78e-05	0.0132	CbGpPWpGaD
Cefepime—SLC15A1—SLC-mediated transmembrane transport—SLC17A5—melanoma	2.77e-05	0.0132	CbGpPWpGaD
Cefepime—SLC22A5—Transmembrane transport of small molecules—ABCB5—melanoma	2.74e-05	0.0131	CbGpPWpGaD
Cefepime—SLC22A5—SLC-mediated transmembrane transport—SLC17A5—melanoma	2.73e-05	0.013	CbGpPWpGaD
Cefepime—SLC15A2—SLC-mediated transmembrane transport—SLC6A11—melanoma	2.71e-05	0.0129	CbGpPWpGaD
Cefepime—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—melanoma	2.58e-05	0.0123	CbGpPWpGaD
Cefepime—SLC15A1—SLC-mediated transmembrane transport—SLC6A11—melanoma	2.52e-05	0.012	CbGpPWpGaD
Cefepime—SLC22A5—SLC-mediated transmembrane transport—SLC6A11—melanoma	2.48e-05	0.0118	CbGpPWpGaD
Cefepime—SLC15A2—Transmembrane transport of small molecules—ARL2—melanoma	2.08e-05	0.00991	CbGpPWpGaD
Cefepime—SLC15A1—Transmembrane transport of small molecules—ARL2—melanoma	1.93e-05	0.0092	CbGpPWpGaD
Cefepime—SLC22A5—Transmembrane transport of small molecules—ARL2—melanoma	1.9e-05	0.00905	CbGpPWpGaD
Cefepime—SLC15A2—Transmembrane transport of small molecules—SLC17A5—melanoma	1.52e-05	0.00723	CbGpPWpGaD
Cefepime—SLC15A1—Transmembrane transport of small molecules—SLC15A2—melanoma	1.46e-05	0.00697	CbGpPWpGaD
Cefepime—SLC22A5—Transmembrane transport of small molecules—SLC15A2—melanoma	1.44e-05	0.00686	CbGpPWpGaD
Cefepime—SLC15A1—Transmembrane transport of small molecules—SLC17A5—melanoma	1.41e-05	0.00671	CbGpPWpGaD
Cefepime—SLC22A5—Transmembrane transport of small molecules—SLC17A5—melanoma	1.39e-05	0.0066	CbGpPWpGaD
Cefepime—SLC15A2—Transmembrane transport of small molecules—SLC6A11—melanoma	1.38e-05	0.00657	CbGpPWpGaD
Cefepime—SLC15A1—Transmembrane transport of small molecules—SLC6A11—melanoma	1.28e-05	0.00609	CbGpPWpGaD
Cefepime—SLC22A5—Transmembrane transport of small molecules—SLC6A11—melanoma	1.26e-05	0.00599	CbGpPWpGaD
Cefepime—SLC15A2—SLC-mediated transmembrane transport—SLC5A5—melanoma	1.24e-05	0.00591	CbGpPWpGaD
Cefepime—SLC15A1—SLC-mediated transmembrane transport—SLC5A5—melanoma	1.15e-05	0.00548	CbGpPWpGaD
Cefepime—SLC22A5—SLC-mediated transmembrane transport—SLC5A5—melanoma	1.13e-05	0.00539	CbGpPWpGaD
Cefepime—SLC15A2—Transmembrane transport of small molecules—SLC5A5—melanoma	6.31e-06	0.003	CbGpPWpGaD
Cefepime—SLC15A2—SLC-mediated transmembrane transport—ALB—melanoma	5.92e-06	0.00282	CbGpPWpGaD
Cefepime—SLC15A1—Transmembrane transport of small molecules—SLC5A5—melanoma	5.85e-06	0.00279	CbGpPWpGaD
Cefepime—SLC22A5—Transmembrane transport of small molecules—SLC5A5—melanoma	5.76e-06	0.00274	CbGpPWpGaD
Cefepime—SLC15A1—SLC-mediated transmembrane transport—ALB—melanoma	5.49e-06	0.00262	CbGpPWpGaD
Cefepime—SLC22A5—SLC-mediated transmembrane transport—ALB—melanoma	5.4e-06	0.00257	CbGpPWpGaD
Cefepime—SLC15A2—Transmembrane transport of small molecules—ABCB1—melanoma	4.81e-06	0.00229	CbGpPWpGaD
Cefepime—SLC15A1—Transmembrane transport of small molecules—ABCB1—melanoma	4.46e-06	0.00212	CbGpPWpGaD
Cefepime—SLC22A5—Transmembrane transport of small molecules—ABCB1—melanoma	4.39e-06	0.00209	CbGpPWpGaD
Cefepime—SLC15A2—Transmembrane transport of small molecules—ALB—melanoma	3.01e-06	0.00143	CbGpPWpGaD
Cefepime—SLC15A1—Transmembrane transport of small molecules—ALB—melanoma	2.79e-06	0.00133	CbGpPWpGaD
Cefepime—SLC22A5—Transmembrane transport of small molecules—ALB—melanoma	2.75e-06	0.00131	CbGpPWpGaD
